Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Follicular lymphomas: do histologic subtypes predict outcome?

T P Miller1, M LeBlanc, T M Grogan

  • 1University of Arizona, Tucson, USA.

Hematology/Oncology Clinics of North America
|October 23, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson in the bb[over ¯] Final State Using pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Magnetic Monopole Pair Production in Ultraperipheral Pb+Pb Collisions at sqrt[s_{NN}]=5.36  TeV with the ATLAS Detector at the LHC.

Physical review letters·2025
Same author

Simultaneous Unbinned Differential Cross-Section Measurement of Twenty-Four Z+jets Kinematic Observables with the ATLAS Detector.

Physical review letters·2025
Same author

Disentangling Sources of Momentum Fluctuations in Xe+Xe and Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Light Long-Lived Particles in pp Collisions at sqrt[s]=13  TeV Using Displaced Vertices in the ATLAS Inner Detector.

Physical review letters·2024
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Histologic subtypes of follicular lymphoma do not appear to impact patient outcomes. This study analyzed a large patient cohort over 25 years, clarifying long-standing debates on follicular lymphoma classification and prognosis.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Histologic subtypes of follicular lymphoma have been debated regarding their unique prognostic value.
  • Previous studies were limited by small sample sizes, heterogeneous factors, and short follow-up periods.
  • The Revised European-American Lymphoma (REAL) classification proposal added complexity to the debate.

Purpose of the Study:

  • To investigate the association between histologic subtypes of follicular lymphoma and patient outcomes.
  • To provide clarity on the long-standing controversy regarding follicular lymphoma subtypes and prognosis.
  • To leverage a large patient cohort with similar stage and treatment for extended follow-up.

Main Methods:

  • Analysis of a large patient group diagnosed with follicular lymphoma.

Related Experiment Videos

  • Inclusion of patients with similar disease stage and treatment regimens.
  • Longitudinal follow-up of patients for up to 25 years.

    • Main Results:

    • Histologic subtypes of follicular lymphoma did not demonstrate unique associations with patient outcomes.
    • The study provides robust evidence against distinct prognostic significance of different follicular lymphoma subtypes.
    • Findings suggest that other factors may be more critical in determining follicular lymphoma prognosis.

    Conclusions:

    • Histologic classification alone is not a significant predictor of outcomes in follicular lymphoma.
    • The findings contribute to a more unified understanding of follicular lymphoma prognosis.
    • Further research should focus on other prognostic markers beyond histologic subtypes.